Concepedia

Jill Gallagher

JG

10

Publications

696

Citations

10

H-Index

1968

Active since

Affiliations

Critical Path Institute(Current)

Parkinson's UK

Pfizer (United States)

Newcastle University

Merck & Co., Inc., Rahway, NJ, USA (United States)

Jill Gallagher is an author at Critical Path Institute specializing in medicine, neurology, and neurodegenerative diseases.

Top concepts

Publications per year

1968–2021

10

Publications

10

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 188 citations · Full text

Appraisal and psychological distress six months after diagnosis of breast cancer

Jill Gallagher, Michael Parle, David Cairns · British Journal of Health Psychology · 2002 · 176 citations

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra et al. · The Lancet Neurology · 2019 · 88 citations · Full text

Primitive reflex activity in primary and symptomatic Parkinsonism.

John Pearce, Hasan Ibn Aziz, Jill Gallagher · Journal of Neurology Neurosurgery & Psychiatry · 1968 · 57 citations · Full text

Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage

Rustam Al‐Shahi Salman, Martin Dennis, Peter Sandercock et al. · JAMA Neurology · 2021 · 47 citations · Full text

Rows per page

1–5 of 10